108 articles
South Korea is building autonomous AI-powered labs to design and test new materials 24/7, potentially cutting development cycles from 10-20 years to just a...
Combining quantum computing with AI could transform genomic medicine by analyzing genetic data far faster, enabling personalized treatment in hours instead of...
Isomorphic Labs, DeepMind's biotech spinoff, is preparing to test AI-designed drugs in humans, marking the first clinical trials of molecules created entirely...
The AI-powered antibody discovery market is projected to grow from $530 million to $4.84 billion by 2035, driven by generative AI and machine learning solving...
Congress faces pressure to reject a proposed $1.3 billion cut to the Department of Energy's Office of Science, which funds critical AI and materials research.
A.D.A.M. Innovations unveiled GeneLock, the world's first genetic data protection platform using fragmentation and decentralized security to protect DNA as...
Pfizer's landmark deal with Boltz PBC signals a major shift: pharmaceutical giants are embracing open-source AI models for protein prediction, blending...
AI-powered robots are automating cell cultivation for regenerative medicine, cutting development time and costs while enabling personalized treatments tailored...
Researchers used AI-accelerated GPUs to solve quantum chemistry calculations once considered too complex to tackle, opening doors to designing new catalysts...
Long-read sequencing technology is finally resolving genomic regions too complex for traditional methods, enabling researchers to develop targeted therapies...
A Barry Goldwater Scholar is developing AI to predict protein-metal interactions that AlphaFold can't, potentially accelerating drug discovery for rare...
NVIDIA and Eli Lilly are investing up to $1 billion over five years in a co-innovation lab that pairs AI researchers with pharmaceutical scientists to...
AI-powered automation is transforming organoid research from a labor-intensive art into a scalable science, enabling faster drug discovery and reducing...
Insilico Medicine's Pharma.AI platform has moved beyond theory, with its first AI-discovered drug entering human trials and showing promising safety data.
Engineers at Northwestern University created printed artificial neurons that successfully communicate with living brain cells, potentially revolutionizing...
Researchers at Mayo Clinic and Goodfire used AI interpretability to predict which genetic mutations cause disease and explain why, outperforming existing tools...
AI materials discovery is hitting a critical bottleneck: machine learning models trained on data alone miss the fundamental physics that governs how materials...
AI is transforming how genomics companies diagnose diseases and improve test accuracy, with companies like Natera leading a sector projected to grow 11.4%...
DeepMind's AlphaFold cracked the protein-folding problem and revealed 200 million protein structures, accelerating aging-reversal research by decades.
AI drug discovery is hitting a wall: models are getting smarter, but the biological data they need is fragmented and outdated.
Google DeepMind's AlphaFold solved protein folding, sparking a wave of AI drug discovery tools that's reshaping how pharma companies approach R&D and...
OpenAI launches GPT-Rosalind, an AI model designed to accelerate drug discovery by tackling bottlenecks in early research stages.
IBM and the University of Illinois are expanding their partnership to merge quantum computing with AI systems, creating a new architecture designed to solve...
Tech billionaires backing AI are now funding genetic optimization startups to create smarter humans who can control superintelligent machines.
A new AI system called StableOx-Cat lets researchers discover stable metal oxide materials for clean energy using plain English instead of programming,...
AI systems autonomously designed and executed 36,000 biological experiments in weeks, cutting protein production costs by 40%, but safety regulations haven't...
Los Alamos National Laboratory unveiled URSA, an AI agent that collaborates with scientists to design and run experiments autonomously.
AI systems can now identify cancer's master genetic switches and design personalized treatments by programming tumor cells against themselves, moving beyond...
DeepMind's Demis Hassabis warns that AI's real competitive edge lies in invisible tools like AlphaFold, not consumer chatbots.
ATLANT 3D and National University of Singapore are building an AI-driven materials discovery foundry that combines atomic-scale manufacturing with artificial...
DeepMind's CEO argues that AI's greatest value comes from solving humanity's hardest scientific problems, not just optimizing operations.
Researchers at University of Rochester used large language models to cut catalyst discovery from 360,000 possible experiments down to just 10, earning $3...
AI is accelerating discovery of sustainable materials like high-capacity batteries and carbon capture tech, but experts warn the technology itself must run on...
Novo Nordisk partners with OpenAI to accelerate drug discovery using advanced AI, targeting faster identification of promising therapies for obesity and...
Argonne chemists are using AI and robotics to compress catalyst discovery from 15-20 years to under five, potentially solving decades-old chemistry problems...
The AI genomics market is exploding from $1.25 billion to $6.11 billion by 2035, driven by precision medicine and drug discovery.
Amazon launched Amazon Bio Discovery, an AI platform that cuts antibody drug design from months to weeks by combining AI agents with integrated lab testing,...
Geneticists using advanced sequencing and AI tools have mapped the exact gene controlling sex determination, revealing the Y chromosome is degrading at an...
DeepMind's AlphaFold 3 predicts how proteins interact with DNA, RNA, and molecules with 76% accuracy, but the real story isn't the technology,it's what it...
AI-designed drug for lung fibrosis completed trials in 18 months for $6M versus $100-200M traditionally.
Weill Cornell Medicine is launching a dual-training program to create researchers fluent in both cancer biology and AI tools, addressing an urgent workforce...
Three-quarters of life-science firms use AI for drug discovery, but only half have governance policies in place.
ProQR Therapeutics partnered with Ginkgo Bioworks to accelerate AI-driven RNA drug discovery, with its first AI-discovered candidate entering clinical trials...
Researchers created a new piezoelectric material that harvests energy from vibration more efficiently than previous versions, potentially eliminating battery...
A landmark partnership between Sheba Medical Center, Mount Sinai, and NVIDIA is using AI to decode the 'dark matter' of the human genome, potentially unlocking...
The University of Arkansas at Little Rock received $12.75 million in federal funding for nanotechnology and advanced research.
A proposed federal bill would sequence genomes from U.S. public lands to build AI-ready datasets for drug discovery.
Researchers discovered theta-phase tantalum nitride, a metallic material with thermal conductivity of 1,100 watts per meter-Kelvin, nearly three times better...
Pharma giants like Eli Lilly and Anthropic are making multibillion-dollar AI deals, signaling that access to algorithms and talent has become as critical to...
A new computational approach called Chemputation merges AI with robotic synthesis to design and manufacture novel molecules autonomously, validated by three...
